Other captive investment companies
JTT AS
Revenue 2024
NOK 0
Operating profit
NOK −105,000
Equity
NOK 46.3m
Incorporated
2009
Share capital
NOK 200,000
Roles
Regnskapsfører
Revisor
Styrets lederJohn Barlindhaug
StyremedlemTuva Barlindhaug
VaramedlemTove Elisabeth Barlindhaug
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| JOHN BARLINDHAUG | 51.0% | 5100.000000 | 2025 |
| TUVA BARLINDHAUG | 49.0% | 4900.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| JPB AS | Active | 40.0% | 20.000000 |
| OBSERVE MEDICAL ASA | Active | 0.7% | 911921.000000 |
| CUBERA IMPACT 2022 INVEST AS | Active | 0.3% | 1250.000000 |
| LYTIX BIOPHARMA ASA | Active | 0.3% | 171249.000000 |
| CUBERA PRIVATE EQUITY 2021 INVEST AS | Active | 0.2% | 1500.000000 |
| PHARMASUM THERAPEUTICS AS | Active | 0.0% | 788.000000 |
| AMICOAT AS | Active | 0.0% | 8368.000000 |
| PHARMA HOLDINGS AS | Active | 0.0% | 167.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.